Hydroxysafflor yellow A: a natural pigment with potential anticancer therapeutic effect
- PMID: 39877386
- PMCID: PMC11772350
- DOI: 10.3389/fphar.2024.1495393
Hydroxysafflor yellow A: a natural pigment with potential anticancer therapeutic effect
Abstract
Hydroxysafflor yellow A (HSYA), a natural pigment with a chalcone structure extracted from Carthamus tinctorius L. (Safflower), has been widely proven to have good efficacy on cardiovascular diseases, atherosclerosis, cancer, and diabetes. However, no study has reported on the anticancer mechanisms of Hydroxysafflor yellow A (HSYA), a principal bioactive compound in safflower. This review discusses recent developments in the physicochemical properties and sources, pharmacological effects and mechanisms, pharmacokinetic progress, and safety of HSYA, focusing on the involvement of HSYA in the regulation of related pathways and mechanisms of apoptosis, autophagy, and the tumor immune microenvironment in a variety of cancers. This can serve as a theoretical basis for further research and development of HSYA, with insights into the mechanisms of anticancer signaling pathways.
Keywords: anticancer effect; hydroxysafflor yellow A; pharmacokinetic progress; pharmacological effects; safety.
Copyright © 2025 Wang, An, Zhou, Chang, Zhang and Peng.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures






Similar articles
-
Hydroxysafflor Yellow A: A Systematical Review on Botanical Resources, Physicochemical Properties, Drug Delivery System, Pharmacokinetics, and Pharmacological Effects.Front Pharmacol. 2020 Dec 11;11:579332. doi: 10.3389/fphar.2020.579332. eCollection 2020. Front Pharmacol. 2020. PMID: 33536906 Free PMC article. Review.
-
Hydroxysafflor Yellow A: A Promising Therapeutic Agent for a Broad Spectrum of Diseases.Evid Based Complement Alternat Med. 2018 Sep 25;2018:8259280. doi: 10.1155/2018/8259280. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30356354 Free PMC article. Review.
-
Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L with good effect of alleviating atherosclerosis.Phytomedicine. 2021 Oct;91:153694. doi: 10.1016/j.phymed.2021.153694. Epub 2021 Aug 4. Phytomedicine. 2021. PMID: 34403879 Review.
-
Pharmacological Actions, Molecular Mechanisms, Pharmacokinetic Progressions, and Clinical Applications of Hydroxysafflor Yellow A in Antidiabetic Research.J Immunol Res. 2021 Dec 13;2021:4560012. doi: 10.1155/2021/4560012. eCollection 2021. J Immunol Res. 2021. PMID: 34938814 Free PMC article. Review.
-
Comparative Analysis of the Effects of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B in Safflower Series of Herb Pairs Using Prep-HPLC and a Selective Knock-Out Approach.Molecules. 2016 Nov 6;21(11):1480. doi: 10.3390/molecules21111480. Molecules. 2016. PMID: 27827969 Free PMC article.
Cited by
-
Combination of Sodium Butyrate and Immunotherapy in Glioma: regulation of immunologically hot and cold tumors via gut microbiota and metabolites.Front Immunol. 2025 Apr 14;16:1532528. doi: 10.3389/fimmu.2025.1532528. eCollection 2025. Front Immunol. 2025. PMID: 40297576 Free PMC article.
-
Hydroxysafflor yellow A alleviates oxidative stress and inflammatory damage in the livers of mice with nonalcoholic fatty liver disease and modulates gut microbiota.Front Pharmacol. 2025 Jun 6;16:1568608. doi: 10.3389/fphar.2025.1568608. eCollection 2025. Front Pharmacol. 2025. PMID: 40548050 Free PMC article.
-
A Comprehensive Review on Exploring the Potential of Phytochemicals and Biogenic Nanoparticles for the Treatment of Antimicrobial-Resistant Pathogenic Bacteria.Curr Microbiol. 2025 Jan 18;82(2):90. doi: 10.1007/s00284-025-04064-w. Curr Microbiol. 2025. PMID: 39825917 Review.
References
-
- Agnieszka S. C., Magdalena M. D., Jadwiga D., Martyna K. S. (2013). Butein inhibits ethanol-induced activation of liver stellate cells through TGF-β, NFκB, p38, and JNK signaling pathways and inhibition of oxidative stress. J. Gastroenterol. 48 (2), 222–237. 10.1007/s00535-012-0619-7 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources